Curis (CRIS) Other Non-Current Liabilities (2010 - 2026)
Curis (CRIS) reported Other Non-Current Liabilities of $1.9 million for Q1 2026, down 93.94% quarter-over-quarter from $31.3 million in Q1 2024.
Curis (CRIS) Other Non-Current Liabilities (2010 - 2026) Analysis & Trends
Curis has reported Other Non-Current Liabilities for 14 years, with the latest figure at $1.9 million in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Liabilities changed N/A year-over-year to $1.9 million; the trailing twelve-month figure through Mar 2026 stood at $1.9 million (changed N/A YoY), and the FY2023 full-year result was $34.1 million, down 21.11% from the prior year.
- Other Non-Current Liabilities for Q1 2026 stood at $1.9 million, down from $31.3 million in the prior quarter.
- The five-year high for Other Non-Current Liabilities was $43.2 million in Q4 2022, with the low at $1.9 million in Q1 2026.
- Historically, Other Non-Current Liabilities has averaged $27.6 million across 4 years, with a median of $32.7 million in 2023.
- The largest YoY upside for Other Non-Current Liabilities was 21.11% in 2023 against a maximum downside of 21.11% in 2023.
- Curis' Other Non-Current Liabilities stood at $43.2 million in 2022, then decreased by 21.11% to $34.1 million in 2023, then declined by 8.13% to $31.3 million in 2024, then slumped by 93.94% to $1.9 million in 2026.
- The last three Other Non-Current Liabilities figures came in at $1.9 million (Q1 2026), $31.3 million (Q1 2024), and $34.1 million (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Curis | 8.58 Mn | -6.42 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.90 Mn |
| Mar 31, 2024 | 31.33 Mn |
| Dec 31, 2023 | 34.10 Mn |
| Dec 31, 2022 | 43.23 Mn |
| Dec 31, 2020 | 334,000.00 |
| Dec 31, 2018 | 11,000.00 |
| Sep 30, 2018 | 29,000.00 |
| Jun 30, 2018 | 46,000.00 |
| Mar 31, 2018 | 63,000.00 |
| Dec 31, 2017 | 34,000.00 |
| Dec 31, 2016 | 18,000.00 |
| Sep 30, 2016 | 41,000.00 |
| Jun 30, 2016 | 62,000.00 |
| Mar 31, 2016 | 83,726.00 |
| Dec 31, 2015 | 139,000.00 |
| Sep 30, 2015 | 148,745.00 |
| Jun 30, 2015 | 158,533.00 |
| Mar 31, 2015 | 168,319.00 |
| Dec 31, 2014 | 174,018.00 |
| Sep 30, 2014 | 187,420.00 |